WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018082814) USE OF 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE IN THE TREATMENT OF CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/082814 International Application No.: PCT/EP2017/001284
Publication Date: 11.05.2018 International Filing Date: 06.11.2017
IPC:
A61K 31/502 (2006.01) ,A61P 25/00 (2006.01) ,A61P 25/28 (2006.01) ,A61K 45/06 (2006.01)
Applicants: METRIOPHARM AG[CH/CH]; Bleicherweg 45 8002 Zurich, CH
Inventors: BRYSCH, Wolfgang; DE
KAISER, Astrid; DE
VAN LAAK, Claudia; DE
LUDESCHER, Beate; DE
SHAH, Maliha; DE
VON WEGERER, Jörg; DE
Priority Data:
16002355.207.11.2016EP
Title (EN) USE OF 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE IN THE TREATMENT OF CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS
(FR) UTILISATION DE 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE DANS LE TRAITEMENT DE LA SCLÉROSE EN PLAQUES PROGRESSIVE CHRONIQUE
Abstract:
(EN) The invention relates to 5-amino-2,3-dihydro-1,4-phthalazinedione or related compounds, compositions or combinations thereof, for use in the treatment of chronic progressive multiple sclerosis, in particular primary and secondary progressive multiple sclerosis. The invention in particular relates to the use of 5-amino-2,3-dihydro-1,4-phthalazinedione sodium salt for said purposes.
(FR) L'invention concerne le 5-amino-2,3-dihydro-1,4-phthalazinedione ou des composés apparentés, des compositions ou des combinaisons de ceux-ci, destinés à être utilisés dans le traitement de la sclérose en plaques progressive chronique, en particulier la sclérose en plaques progressive primaire et secondaire. L'invention concerne en particulier l'utilisation de sel de sodium de 5-amino-2,3-dihydro-1,4-phthalazinedione.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)